177 related articles for article (PubMed ID: 8082757)
1. Secretory cleavage site of Alzheimer amyloid precursor protein is heterogeneous in Down's syndrome brain.
Kametani F; Tanaka K; Tokuda T; Ikeda S
FEBS Lett; 1994 Sep; 351(2):165-7. PubMed ID: 8082757
[TBL] [Abstract][Full Text] [Related]
2. Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity.
Kametani F; Tanaka K; Ishii T; Ikeda S; Kennedy HE; Allsop D
Biochem Biophys Res Commun; 1993 Mar; 191(2):392-8. PubMed ID: 8460999
[TBL] [Abstract][Full Text] [Related]
3. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
[TBL] [Abstract][Full Text] [Related]
4. Secretory cleavage of beta-amyloid precursor protein in the cerebral white matter produces amyloidogenic carboxyl-terminal fragments.
Tokuda T; Tanaka K; Kametani F; Ikeda S; Yanagisawa N
Neurosci Lett; 1995 Feb; 186(2-3):149-52. PubMed ID: 7539900
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
6. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome.
Beyreuther K; Pollwein P; Multhaup G; Mönning U; König G; Dyrks T; Schubert W; Masters CL
Ann N Y Acad Sci; 1993 Sep; 695():91-102. PubMed ID: 8239320
[TBL] [Abstract][Full Text] [Related]
7. Secretory form of beta-amyloid precursor protein is much abundantly contained in the cerebral white matter in human brain.
Tokuda T; Tanaka K; Kametani F; Ikeda S; Yanagisawa N
Neurosci Lett; 1994 Jul; 175(1-2):33-6. PubMed ID: 7970206
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and control brain contain soluble derivatives of the amyloid protein precursor that end within the beta amyloid protein region.
Pasternack JM; Palmert MR; Usiak M; Wang R; Zurcher-Neely H; Gonzalez-De Whitt PA; Fairbanks MB; Cheung T; Blades D; Heinrikson RL
Biochemistry; 1992 Nov; 31(44):10936-40. PubMed ID: 1420205
[TBL] [Abstract][Full Text] [Related]
9. Plasma amyloid precursor protein is decreased in Alzheimer's disease.
Martins RN; Muir J; Brooks WS; Creasey H; Montgomery P; Sellers P; Broe GA
Neuroreport; 1993 Jun; 4(6):757-9. PubMed ID: 8347821
[TBL] [Abstract][Full Text] [Related]
10. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
11. Advanced Assay Monitoring APP-Carboxyl-Terminal Fragments as Markers of APP Processing in Alzheimer Disease Mouse Models.
García-Osta A; Cuadrado-Tejedor M
Methods Mol Biol; 2016; 1303():117-23. PubMed ID: 26235062
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
Multhaup G; Mechler H; Masters CL
J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
[TBL] [Abstract][Full Text] [Related]
13. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
[TBL] [Abstract][Full Text] [Related]
14. Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease.
Sergeant N; David JP; Champain D; Ghestem A; Wattez A; Delacourte A
J Neurochem; 2002 May; 81(4):663-72. PubMed ID: 12065626
[TBL] [Abstract][Full Text] [Related]
15. Secretion of beta-amyloid precursor protein involves multiple cleavage sites.
Zhong Z; Higaki J; Murakami K; Wang Y; Catalano R; Quon D; Cordell B
J Biol Chem; 1994 Jan; 269(1):627-32. PubMed ID: 8276862
[TBL] [Abstract][Full Text] [Related]
16. Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels.
Tamaoka A; Kalaria RN; Lieberburg I; Selkoe DJ
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1345-9. PubMed ID: 1531538
[TBL] [Abstract][Full Text] [Related]
17. Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells.
Baskin F; Rosenberg RN; Greenberg BD
J Neurosci Res; 1991 May; 29(1):127-32. PubMed ID: 1909380
[TBL] [Abstract][Full Text] [Related]
18. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
[TBL] [Abstract][Full Text] [Related]
19. A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.
Ghiso J; Rostagno A; Gardella JE; Liem L; Gorevic PD; Frangione B
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):1053-9. PubMed ID: 1281980
[TBL] [Abstract][Full Text] [Related]
20. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
